296 Review Article Imaging of pulmonary hypertension: an update Harold Goerne1,2, Kiran Batra3, Prabhakar Rajiah3 1IMSS Centro Medico Nacional De Occidente, Guadalajara, Jalisco, Mexico; 2CID Imaging and Diagnostic Center, Guadalajara, Jalisco, Mexico; 3Radiology Department, UT Southwestern Medical Center, Dallas, Texas, USA Contributions: (I) Conception and design: H Goerne, P Rajiah; (II) Administrative support: H Goerne, P Rajiah; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: H Goerne, P Rajiah; (V) Data analysis and interpretation: H Goerne, P Rajiah; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Prabhakar Rajiah, MD. Associate Professor, Department of Radiology, Cardiothoracic Imaging, UT Southwestern Medical Center, E6.120 B, Mail code 9316, 5323 Harry Hines Boulevard, Dallas, TX 75390-8896, USA. Email:
[email protected]. Abstract: Pulmonary hypertension (PH) is characterized by elevated pulmonary arterial pressure caused by a broad spectrum of congenital and acquired disease processes, which are currently divided into five groups based on the 2013 WHO classification. Imaging plays an important role in the evaluation and management of PH, including diagnosis, establishing etiology, quantification, prognostication and assessment of response to therapy. Multiple imaging modalities are available, including radiographs, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine, echocardiography and